- Home
- BIP vs ICLR Comparison
BIP vs ICLR Comparison
Compare BIP & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIP
- ICLR
- Stock Information
- Founded
- BIP 2007
- ICLR 1990
- Country
- BIP Bermuda
- ICLR Ireland
- Employees
- BIP N/A
- ICLR N/A
- Industry
- BIP Marine Transportation
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- BIP Consumer Discretionary
- ICLR Health Care
- Exchange
- BIP Nasdaq
- ICLR Nasdaq
- Market Cap
- BIP 14.7B
- ICLR 13.7B
- IPO Year
- BIP 2008
- ICLR 1998
- Fundamental
- Price
- BIP $30.83
- ICLR $170.46
- Analyst Decision
- BIP Strong Buy
- ICLR Buy
- Analyst Count
- BIP 4
- ICLR 15
- Target Price
- BIP $43.50
- ICLR $209.93
- AVG Volume (30 Days)
- BIP 532.9K
- ICLR 1.0M
- Earning Date
- BIP 11-05-2025
- ICLR 10-22-2025
- Dividend Yield
- BIP 5.58%
- ICLR N/A
- EPS Growth
- BIP N/A
- ICLR 13.11
- EPS
- BIP 0.08
- ICLR 9.73
- Revenue
- BIP $21,535,000,000.00
- ICLR $8,089,820,000.00
- Revenue This Year
- BIP N/A
- ICLR N/A
- Revenue Next Year
- BIP N/A
- ICLR $1.73
- P/E Ratio
- BIP $374.53
- ICLR $17.98
- Revenue Growth
- BIP 8.86
- ICLR N/A
- 52 Week Low
- BIP $25.72
- ICLR $125.10
- 52 Week High
- BIP $36.50
- ICLR $310.54
- Technical
- Relative Strength Index (RSI)
- BIP 48.95
- ICLR 48.26
- Support Level
- BIP $30.51
- ICLR $164.00
- Resistance Level
- BIP $31.07
- ICLR $180.95
- Average True Range (ATR)
- BIP 0.60
- ICLR 6.50
- MACD
- BIP 0.04
- ICLR -1.10
- Stochastic Oscillator
- BIP 38.14
- ICLR 43.63
About BIP Brookfield Infrastructure Partners LP
Brookfield Infrastructure Partners LP is a Bermuda exempted limited partnership that owns and operates quality, long-life assets that generate stable cash flows, by virtue of barriers to entry or other characteristics that tend to appreciate in value over time. It focuses on acquiring infrastructure assets that have low maintenance capital costs and high barriers to entry. The company's segments consist of Utilities, Transport, Midstream, and Data. Geographically, it generates maximum revenue from USA and also has a presence in Australia, Colombia, United Kingdom, Brazil, United States of America, Chile, Peru, and other countries.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.